Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 10, 2016, Pages 908-914

  Huang, H ^a   Zheng, T ^a   Wang, S ^a   Wei, L ^b   Wang, Q ^b   Sun, Z ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

25 Hydroxyvitamin D; Chinese; Ischemic stroke; Stroke recurrence

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; HOMOCYSTEINE; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; VITAMIN SUPPLEMENTATION; AGED; ANALOGS AND DERIVATIVES; BLOOD; CHINA; COMPARATIVE STUDY; DOWN REGULATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL MODEL; STROKE; TIME FACTOR; VITAMIN D DEFICIENCY;

AGED; BIOMARKERS; BRAIN ISCHEMIA; CHINA; DOWN-REGULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84995470023     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2016.06.009     Document Type: Article

References (39)

1. [1] Wang, Y., Zhao, X., Liu, L., Soo, Y.O., Pu, Y., Pan, Y., et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) study. Stroke 45:3 (2014), 663–669.
2. [2] Zhang, Q., Ding, H., Yan, J., Wang, W., Ma, A., Zhu, Z., et al. Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case–control study in China. Ann Neurol 70:2 (2011), 265–273.
3. [3] Makariou, S., Michel, P., Tzoufi, M., Challa, A., Milionis, H.J., Vitamin D and stroke: promise for prevention and better outcome. Curr Vasc Pharmacol 12:1 (2014), 117–124.
4. [4] Brøndum-Jacobsen, P., Nordestgaard, B.G., Schnohr, P., Benn, M., 25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol 73:1 (2013), 38–47.
5. [5] Gupta, A., Prabhakar, S., Modi, M., Bhadada, S.K., Lal, V., Khurana, D., Vitamin D status and risk of ischemic stroke in North Indian patients. Indian J Endocrinol Metab, 18(5), 2014, 721.
6. [6] Daubail, B., Jacquin, A., Guilland, J.C., Khoumri, C., Aboa-Eboulé, C., Giroud, M., et al. Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis 37:5 (2014), 364–367.
7. [7] Tu, W.J., Zhao, S.J., Xu, D.J., Chen, H., Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin Sci 126:5 (2014), 339–346.
8. [8] Park, K.Y., Chung, P.W., Kim, Y.B., Moon, H.S., Suh, B.C., Won, Y.S., et al. Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc Dis 40:1–2 (2015), 73–80.
9. [9] Hatano, S., Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54 (1976), 541–553.
10. [10] Brott, T., Adams, H.P. Jr., Olinger, C.P., Marler, J.R., Barsanl, W.G., Biller, J., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989), 864–870.
11. [11] Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24 (1993), 35–41.
12. [12] Bamford, J., Sandercock, P., Dennis, M., Burn, J., Warlow, C., Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991), 1521–1526.
13. [13] Sims, J.R., Gharai, L.R., Schaefer, P.W., Vangel, M., Rosenthal, E.S., ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72 (2009), 2104–2110.
14. [14] Kunadian, V., Ford, G.A., Bawamia, B., Qiu, W., Manson, J.E., Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J 167:3 (2014), 283–291.
15. [15] Pilz, S., Dobnig, H., Fischer, J.E., Wellnitz, B., Seelhorst, U., Boehm, B.O., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39:9 (2008), 2611–2613.
16. [16] Schneider, A.L.C., Lutsey, P.L., Selvin, E., Mosley, T.H., Sharrett, A.R., Carson, K.A., et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol 22:8 (2015), 1220–1227.
17. [17] Judd, S.E., Morgan, C.J., Panwar, B., Howard, V.J., Wadley, V.G., Jenny, N.S., et al. Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke 11:1 (2016), 93–102.
18. [18] Wang, L., Manson, J.A.E., Song, Y., Sesso, H.D., Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152:5 (2010), 315–323.
19. [19] Witham, M.D., Dove, F.J., Sugden, J.A., Doney, A.S., Struthers, A.D., The effect of vitamin D replacement on markers of vascular health in stroke patients – a randomised controlled trial. Nutr Metab Cardiovasc Dis 22:10 (2012), 864–870.
20. [20] Pilz, S., Tomaschitz, A., Drechsler, C., Zittermann, A., Dekker, J.M., März, W., Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 12:1 (2011), 88–96.
21. [21] Ford, J.A., MacLennan, G.S., Avenell, A., Bolland, M., Grey, A., Witham, M., et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100:3 (2014), 746–755.
22. [22] Bolland, M.J., Grey, A., Gamble, G.D., Reid, I.R., The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2:4 (2014), 307–320.
23. [23] Welsh, P., Lowe, G.D., Chalmers, J., Campbell, D.J., Rumley, A., Neal, B.C., et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39:8 (2008), 2226–2230.
24. [24] Weir, C.J., Muir, S.W., Walters, M.R., Lees, K.R., Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34:8 (2003), 1951–1956.
25. [25] Gu, X.L., Liu, L., Lu, X.D., Liu, Z.R., Serum CXCL12 levels as a novel predictor of future stroke recurrence in patients with acute ischemic stroke. Mol Neurobiol 53:5 (2016), 2807–2814.
26. [26] Choi, J.Y., Kim, J.S., Kim, J.H., Oh, K., Koh, S.B., Seo, W.K., High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology 82:13 (2014), 1142–1148.
27. [27] Greisenegger, S., Segal, H.C., Burgess, A.I., Poole, D.L., Mehta, Z., Rothwell, P.M., Copeptin and long-term risk of recurrent vascular events after transient ischemic attack and ischemic stroke population-based study. Stroke 46:11 (2015), 3117–3123.
28. [28] Li, J., Wang, Y., Lin, J., Wang, D., Wang, A., Zhao, X., et al. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack. Stroke 46:7 (2015), 1990–1992.
29. [29] Zhang, W., Sun, K., Chen, J., Liao, Y., Qin, Q., Ma, A., et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci 118:3 (2009), 187–194.
30. [30] Pennlert, J., Eriksson, M., Carlberg, B., Wiklund, P.G., Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke 45:6 (2014), 1839–1841.
31. [31] Howard, G., Kissela, B.M., Kleindorfer, D.O., McClure, L.A., Soliman, E.Z., Judd, S.E., et al. Differences in the role of black race and stroke risk factors for first vs recurrent stroke. Neurology 86:7 (2016), 637–642.
32. [32] Aarnio, K., Haapaniemi, E., Melkas, S., Kaste, M., Tatlisumak, T., Putaala, J., Long-term mortality after first-ever and recurrent stroke in young adults. Stroke 45:9 (2014), 2670–2676.
33. [33] Giang, K.W., Björck, L., Ståhl, C.H., Nielsen, S., Sandström, T.Z., Jern, C., et al. Trends in risk of recurrence after the first ischemic stroke in adults younger than 55 years of age in Sweden. Int J Stroke 11:1 (2016), 52–61.
34. [34] Wang, Y., Xu, J., Zhao, X., Wang, D., Wang, C., Liu, L., et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 44:5 (2013), 1232–1237.
35. [35] Wang, L., Song, Y., Manson, J.E., Pilz, S., März, W., Michaëlsson, K., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5 (2012), 819–829.
36. [36] Song, Y., Wang, L., Pittas, A.G., Del Gobbo, L.C., Zhang, C., Manson, J.E., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes a meta-analysis of prospective studies. Diabetes Care 36:5 (2013), 1422–1428.
37. [37] Michos, E.D., Carson, K.A., Schneider, A.L., Lutsey, P.L., Xing, L., Sharrett, A.R., et al. Vitamin D and subclinical cerebrovascular disease: the atherosclerosis risk in communities brain magnetic resonance imaging study. JAMA Neurol 71:7 (2014), 863–871.
38. [38] Welles, C.C., Whooley, M.A., Karumanchi, S.A., Hod, T., Thadhani, R., Berg, A.H., et al. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul study. Am J Epidemiol 179:11 (2014), 1279–1287.
39. [39] O'Rourke, M.F., Safar, M.E., Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46 (2005), 200–204.